Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence: A Prospective Observational Study (NeuroCogPresv)

NCT07477028 is registered in ClinicalTrials.gov with Noah Tech, Corp. as lead sponsor.

NCT NCT07477028
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07477028 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Non-Invasive Detection and Preservation of Neurocognitive Signals in the Peri-Death Period Using Brain-Computer Interface and Artificial Intelligence: A Prospective Observational Study (NeuroCogPresv)
Lead sponsor
Noah Tech, Corp.
Phase
Observational
Overall status
Not yet recruiting
Start date
September 1, 2026
Completion date
September 30, 2035
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain death, cognition, cognitive, consciousness, death, death anxiety, eeg, electroencephalography, end-of-life care, gamma oscillations, memory, near-death phenomena, severe acute trauma, terminal illness